Labcorp (LH)
(Delayed Data from NYSE)
$216.39 USD
+1.49 (0.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $216.35 -0.04 (-0.02%) 7:14 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Revenues: Diagnostics Laboratorie... |
-- | 9,415 | 9,204 | 10,364 | 9,253 | 7,000 |
Revenues: Biopharma Laboratory Se... |
-- | 2,774 | 2,697 | 2,861 | 4,878 | 4,578 |
Revenues: Intercompany eliminatio... |
-- | -28 | -37 | -88 | -153 | -23 |
Income - Line of Business | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Adjusted Operating Income: Diagno... |
-- | 1,591 | 2,026 | 3,206 | 2,801 | 1,229 |
Adjusted Operating Income: Biopha... |
-- | 396 | 389 | 887 | 722 | 638 |
NFM - Operating & Non Financial Metrics | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Net book-to-bill Ratio [%] |
-- | 1 | 1 | 1 | -- | -- |
Ending backlog [B] |
-- | 8 | 16 | 15 | -- | -- |